Difference between revisions of "Template:Drugs for treatment of bone diseases"
Jump to navigation
Jump to search
imported>A915 |
imported>Medgirl131 |
||
| (5 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Drugs for treatment of bone diseases |
| − | | title = Drugs for treatment of [[bone disease]]s ([[ATC code M05|M05]]) | + | | title = Drugs for treatment of [[bone disease]]s ([[ATC code M05|M05]]) |
| − | | state = {{{state|autocollapse}}} | + | | state = {{{state<includeonly>|autocollapse</includeonly>}}} |
| − | |listclass = hlist | + | | listclass = hlist |
| − | |||
| − | | group1 = [[Bisphosphonate]]s | + | | group1 = [[Bisphosphonate]]s |
| − | | | + | | list1 = |
| − | * [[Nitrogen]]ous | + | * [[Nitrogen]]ous |
| − | * [[ | + | ** [[Alendronic acid]] |
| − | * [[ | + | ** [[Ibandronic acid]] |
| − | * [[ | + | ** [[Incadronic acid]] |
| − | * [[ | + | ** [[Neridronic acid]] |
| − | * [[ | + | ** [[Pamidronic acid]] |
| − | * [[ | + | ** [[Risedronic acid]] |
| − | * [[ | + | ** [[Zoledronic acid]] |
| + | * Non-nitrogenous | ||
| + | ** [[Etidronic acid]] | ||
| + | ** [[Clodronic acid]] | ||
| + | ** [[Tiludronic acid]] | ||
| − | | group2 = [[Bone morphogenetic protein]]s | + | | group2 = [[Bone morphogenetic protein]]s |
| − | | | + | | list2 = |
* [[Bone morphogenetic protein 2|Dibotermin alfa]] | * [[Bone morphogenetic protein 2|Dibotermin alfa]] | ||
* [[Eptotermin alfa]] | * [[Eptotermin alfa]] | ||
| − | | group3 = Other | + | | group3 = Other |
| − | | | + | | list3 = |
| − | * ''Resorption inhibitor'' | + | * ''Resorption inhibitor'' |
| + | ** [[Ipriflavone]] | ||
* [[Aluminium chlorohydrate]] | * [[Aluminium chlorohydrate]] | ||
| − | * ''Dual action bone agent'' | + | * ''Dual action bone agent'' |
| − | * | + | ** [[Strontium ranelate]] |
| − | * ''[[Cathepsin K]] inhibitor'' | + | * ''[[RANKL]] inhibitor'' |
| + | ** [[Denosumab]] | ||
| + | * ''[[Sclerostin]] inhibitor'' | ||
| + | ** [[Romosozumab]] | ||
| + | * ''[[Cathepsin K]] inhibitor'' | ||
| + | ** [[Odanacatib]] | ||
| + | * [[Parathyroid hormone-related protein]] [[structural analog|analogue]]s | ||
| + | ** [[Abaloparatide]] | ||
| + | ** [[Teriparatide]] | ||
| + | * [[Calcitonin]] | ||
* [[Calcium]] | * [[Calcium]] | ||
* [[Vitamin D]] | * [[Vitamin D]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
| − | [[Category: | + | [[Category:Drug templates by ATC]] |
| − | |||
</noinclude> | </noinclude> | ||
Latest revision as of 23:21, 11 November 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Drugs for treatment of bone diseases|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Drugs for treatment of bone diseases|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Drugs for treatment of bone diseases|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.